(+34) 93 414 55 66
Contact
Espacio socios y amigos
The Josep Carreras Leukaemia Foundation and the Spanish Group for Haematopoietic Transplantation and Cellular Therapy (GETH-TC) have announced the winning project of the Josep Carreras Grant 2026, a call aimed at promoting clinical research to improve outcomes in bone marrow transplantation.
The grant, endowed with €300,000, was awarded during the Josep Carreras Symposium on the Ideal Donor 2026, held in Málaga as part of the GETH-TC scientific meeting.
The selected project, titled “Comparison between haploidentical transplantation and partially matched unrelated donor transplantation”, is led by Dr. Ignacio Gómez-Centurión and Dr. Mi Kwon, from Hospital Gregorio Marañón in Madrid, together with Dr. María Jesús Pascual, from Málaga Regional Hospital.
The study consists of a prospective randomized clinical trial comparing two key donor selection strategies in haematopoietic transplantation: haploidentical family transplantation and partially matched unrelated donor transplantation. The aim is to generate solid scientific evidence to help medical teams determine which option offers better survival outcomes and fewer complications for patients.
The jury highlighted the innovative nature of the project, as it addresses a clinical question that remains unresolved and has the potential to transform clinical practice in the field of transplantation.
Researchers from hospitals belonging to the GETH-TC network were eligible to apply. This network brings together 73 hospitals across Spain and two in Portugal, making it one of the leading haematopoietic transplantation platforms in southern Europe.
In addition to the winning proposal, the jury evaluated six other high-level multicentre studies, addressing key challenges in bone marrow transplantation such as graft-versus-host disease prevention, new immunotherapy strategies, early relapse detection and improving patient recovery.
With this call, the Josep Carreras Foundation strengthens a new line of support for clinical research in bone marrow transplantation, in line with its long-standing commitment to patients and with Josep Carreras’ legacy in the fight against leukaemia.
